HUT74687A - Pyrrole and thiazolidine derivatives of prolyl endopeptidase inhibitor activity and pharmaceutical compositions containing the same - Google Patents

Pyrrole and thiazolidine derivatives of prolyl endopeptidase inhibitor activity and pharmaceutical compositions containing the same Download PDF

Info

Publication number
HUT74687A
HUT74687A HU9601472A HU9601472A HUT74687A HU T74687 A HUT74687 A HU T74687A HU 9601472 A HU9601472 A HU 9601472A HU 9601472 A HU9601472 A HU 9601472A HU T74687 A HUT74687 A HU T74687A
Authority
HU
Hungary
Prior art keywords
formula
compounds
mmol
pharmaceutical composition
compound
Prior art date
Application number
HU9601472A
Other languages
English (en)
Hungarian (hu)
Other versions
HU9601472D0 (en
Inventor
Joseph P Burkhart
Shujaath Mehdi
Norton P Peet
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Publication of HU9601472D0 publication Critical patent/HU9601472D0/hu
Publication of HUT74687A publication Critical patent/HUT74687A/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pyrrole Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HU9601472A 1993-12-02 1994-11-08 Pyrrole and thiazolidine derivatives of prolyl endopeptidase inhibitor activity and pharmaceutical compositions containing the same HUT74687A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16110693A 1993-12-02 1993-12-02

Publications (2)

Publication Number Publication Date
HU9601472D0 HU9601472D0 (en) 1996-07-29
HUT74687A true HUT74687A (en) 1997-01-28

Family

ID=22579844

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9601472A HUT74687A (en) 1993-12-02 1994-11-08 Pyrrole and thiazolidine derivatives of prolyl endopeptidase inhibitor activity and pharmaceutical compositions containing the same

Country Status (19)

Country Link
US (1) US5661167A (enExample)
EP (1) EP0731788B1 (enExample)
JP (1) JPH09506090A (enExample)
KR (1) KR100341982B1 (enExample)
CN (1) CN1136806A (enExample)
AT (1) ATE223894T1 (enExample)
AU (1) AU684861B2 (enExample)
CA (1) CA2177821C (enExample)
DE (1) DE69431359T2 (enExample)
DK (1) DK0731788T3 (enExample)
ES (1) ES2179093T3 (enExample)
HU (1) HUT74687A (enExample)
IL (1) IL111775A (enExample)
NO (1) NO962238D0 (enExample)
NZ (1) NZ276600A (enExample)
PT (1) PT731788E (enExample)
TW (1) TW280818B (enExample)
WO (1) WO1995015310A1 (enExample)
ZA (1) ZA949302B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5859031A (en) 1995-06-07 1999-01-12 Gpi Nil Holdings, Inc. Small molecule inhibitors of rotamase enzyme activity
JP4806628B2 (ja) 2003-05-05 2011-11-02 プロビオドルグ エージー グルタミニルシクラーゼ阻害剤
EP1824846A2 (en) 2003-11-03 2007-08-29 Probiodrug AG Novel compounds for the treatment of neurological disorders
WO2005049027A2 (en) 2003-11-03 2005-06-02 Probiodrug Ag Combinations useful for the treatment of neuronal disorders
KR101099206B1 (ko) 2004-02-05 2011-12-27 프로비오드룩 아게 신규한 글루타미닐 시클라제 저해제
US8278345B2 (en) 2006-11-09 2012-10-02 Probiodrug Ag Inhibitors of glutaminyl cyclase
JP5523107B2 (ja) 2006-11-30 2014-06-18 プロビオドルグ エージー グルタミニルシクラーゼの新規阻害剤
EP2481408A3 (en) 2007-03-01 2013-01-09 Probiodrug AG New use of glutaminyl cyclase inhibitors
WO2008128985A1 (en) 2007-04-18 2008-10-30 Probiodrug Ag Thiourea derivatives as glutaminyl cyclase inhibitors
WO2008144748A1 (en) * 2007-05-21 2008-11-27 The Uab Research Foundation Prolyl endopeptidase inhibitors for reducing or preventing neutrophilic inflammation
MX2012002993A (es) 2009-09-11 2012-04-19 Probiodrug Ag Derivados heterociclicos como inhibidores de ciclasa glutaminilo.
JP6026284B2 (ja) 2010-03-03 2016-11-16 プロビオドルグ エージー グルタミニルシクラーゼの阻害剤
US8269019B2 (en) 2010-03-10 2012-09-18 Probiodrug Ag Inhibitors
WO2011131748A2 (en) 2010-04-21 2011-10-27 Probiodrug Ag Novel inhibitors
ES2570167T3 (es) 2011-03-16 2016-05-17 Probiodrug Ag Derivados de benzimidazol como inhibidores de glutaminil ciclasa
CA2938369C (en) 2014-01-28 2019-08-06 Spirit Global Energy Solutions, Inc. Down-hole gas and solids separator utilized in production hydrocarbons
PL3461819T3 (pl) 2017-09-29 2020-11-30 Probiodrug Ag Inhibitory cyklazy glutaminylowej

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4518528A (en) * 1983-05-19 1985-05-21 Rasnick David W α Amino fluoro ketones
ZA86746B (en) * 1985-02-04 1986-09-24 Merrell Dow Pharma Novel peptidase inhibitors
DE3712365A1 (de) * 1987-04-11 1988-10-27 Hoechst Ag Neue 2-acylpyrrolidin-derivate, verfahren zu ihrer herstellung, sie enthaltende mittel sowie deren verwendung
US4855303A (en) * 1987-07-01 1989-08-08 Pfizer Inc. Fluorine containing renin inhibitors
JPH0662591B2 (ja) * 1988-12-14 1994-08-17 株式会社ヤクルト本社 新規なチオプロリン誘導体
WO1990012005A1 (fr) * 1989-04-13 1990-10-18 Japan Tobacco Inc. Nouveaux derives aminoacides possedant une activite d'inhibiteur de la prolylendopeptidase

Also Published As

Publication number Publication date
US5661167A (en) 1997-08-26
EP0731788B1 (en) 2002-09-11
DK0731788T3 (da) 2003-01-20
IL111775A0 (en) 1995-01-24
ATE223894T1 (de) 2002-09-15
NZ276600A (en) 1997-09-22
AU1091795A (en) 1995-06-19
CA2177821C (en) 2000-03-28
JPH09506090A (ja) 1997-06-17
DE69431359T2 (de) 2003-07-31
PT731788E (pt) 2003-01-31
CA2177821A1 (en) 1995-06-08
KR100341982B1 (ko) 2002-11-30
ES2179093T3 (es) 2003-01-16
EP0731788A1 (en) 1996-09-18
DE69431359D1 (de) 2002-10-17
WO1995015310A1 (en) 1995-06-08
IL111775A (en) 1998-06-15
HU9601472D0 (en) 1996-07-29
AU684861B2 (en) 1998-01-08
NO962238L (no) 1996-05-31
NO962238D0 (no) 1996-05-31
CN1136806A (zh) 1996-11-27
TW280818B (enExample) 1996-07-11
ZA949302B (en) 1995-08-07

Similar Documents

Publication Publication Date Title
AU600226B2 (en) Novel peptidase inhibitors
US5496927A (en) Peptidase inhibitors
CA2338524C (en) Inhibitors of urokinase and blood vessel formation
US4692458A (en) Anti-hypertensive agents
EP0731788B1 (en) Prolyl endopeptidase inhibitors
JP4489976B2 (ja) 補体プロテアーゼの低分子インヒビター
HU203369B (en) Process for producing enzyme inhibiting dipeptidecarbamoyl derivatives and pharmaceutical compositions comprising same
EP1465891A2 (en) Inhibitors of dipeptidyl peptidase iv
US4745124A (en) Orally effective anti-hypertensive agents
HUP0001826A2 (hu) Új trombin inhibitorok
JP2001518084A (ja) Ｃ−末端にカルボニル基及び複素環基を有するドラスタチン１５誘導体
US5852051A (en) Dipeptide p-amidinobenzylamides with N-terminal sulfonyl or aminosulfonyl radicals
EP0344682B1 (de) Oligopeptide mit zyklischen Prolin-analogen Aminosäuren
KR100689923B1 (ko) 트롬빈 억제제
JP2004503563A (ja) 凝固因子Ｘａ阻害剤
US6693072B2 (en) Elastase inhibitors
US6417161B1 (en) Amino acid amidinohydrazones, alkoxyguanidines and aminoguanidines as protease inhibitors
US4734420A (en) Anti-hypertensive agents
US4833152A (en) Anti-hypertensive agents
US4690936A (en) Anti-hypertensive agents
KR100565008B1 (ko) 4-하이드라지노-3-사이클로부텐-1,2-다이온 유도체 및이들의 제조 방법
EP1140984A1 (en) Selective inhibitors of mmp-12
CZ20002463A3 (cs) Nové inhibitory trombinu
MXPA00010379A (en) Cysteine protease inhibitors

Legal Events

Date Code Title Description
DFC4 Cancellation of temporary protection due to refusal